Sign in
Taking people in South AfricaNo phase

Testing a bottle-based teaching tool to explain HIV and its treatment in South Africa

Tests B-OK bottles for teaching HIV treatment to adults in South Africa.

Key facts

Who runs it
University of Pennsylvania
Where
Johannesburg, South AfricaSee the site
Trial code
Registry title
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
Status
Recruiting
People taking part
600 people, planned
Started
27 Jul 2026
Expected to end
Mar 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • B-OK Bead Bottles Intervention (delivered in person)
  • B-OK Bottles Intervention (delivered by video)
  • Control
Record updated
6 November 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults living in Gauteng, South Africa. It tests whether B-OK bottles help people understand HIV and antiretroviral therapy (ART).

Age
18 years or older
Sex
All sexes can join.

Main reasons for not taking part

  • Unwilling or unable to give written informed consent

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Aged 18 years or older
  • Residing in Gauteng
  • Able to understand and communicate in English or another study-supported language
  • Willing to attend an in-person study visit at the HE2RO offices
  • Willing to provide contact details for follow-up at six weeks

Who cannot take part

  • Unwilling or unable to provide written informed consent for study participation

This trial is currently available in South Africa.

  • Health Economics and Epidemiology Research Office (HE2RO), University of the WitwatersrandJohannesburg, South AfricaContact: Caroline Govathson, PhDTaking people

About the trial

What the trial wants to find out

Consistent use of antiretroviral therapy (ART) is essential for achieving suppression among people with HIV (PWH). Yet despite improvements in access to ART and improving viral suppression rates, an estimated one-third of PWH globally do not take ART as prescribed, thus allowing the virus to remain detectable and transmissible. This study tests whether a low-cost visual education tool, B-OK bottles, improves understanding of HIV, antiretroviral therapy (ART), and the concept of Undetectable = Untransmittable (U=U) among adults in Gauteng, South Africa using a randomized trial. Participants will be randomly assigned to one of three groups: (1) standard-of-care verbal information based on Department of Health guidelines, (2) information delivered in person using B-OK bottles, or (3) information delivered via a video demonstrating the B-OK bottles. The study will compare the two intervention formats to standard care, and to each other, to assess whether the tool improves knowledge, attitudes, and intentions related to HIV treatment and prevention, and whether the intervention results depend on delivery mode (in-person vs. video). Outcomes will be measured at baseline, immediately after the intervention, and at six-week follow-up.

The 3 groups in the trial

  • ControlExisting treatment, for comparison

    Participants enrolled in the control group will receive standard-of-care verbal information about HIV and ART based on South African Department of Health guidelines, delivered via standardized script.

  • B-OK Bottles Intervention (delivered in person)Treatment being tested

    Participants enrolled in this group will receive information about HIV and ART that is communicated using B-OK bottles as visual aids to make the information more salient. The bottles explain how HIV affects a person's health and how ART reduces viral load and eliminates HIV transmission risk.

    Treatment: B-OK Bead Bottles Intervention (delivered in person)

  • B-OK Bottles Intervention (delivered by video)Treatment being tested

    Participants enrolled in this group will receive information about HIV and ART in the form of a video that illustrates B-OK. The video will use the bottles to explain how HIV affects a person's health and how ART reduces viral load and eliminates HIV transmission risk.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Evaluating the Impact of Using the B-OK Bottles for HIV and ART Literacy in South Africa
Plain-language title
Testing a bottle-based teaching tool to explain HIV and its treatment in South AfricaGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 13 November 2026.
Record updated
6 November 2026